1. Interleukin 1β –511 C/T polymorphism and risk of aneurysmal subarachnoid haemorrhage. Issue 2 (17th January 2006) Authors: Slowik, A; Borratynska, A; Turaj, W; Pera, J; Dziedzic, T; Wloch, D; Szczudlik, A; Betlej, M; Krzyszkowski, T; Czepko, R Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 77:Issue 2(2006) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lack of association between interleukin-1β polymorphism (−511) and ischaemic stroke. Issue 1 (5th January 2004) Authors: Dziedzic, T; Slowik, A; Pera, J; Szczudlik, A Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 75:Issue 1(2004) Page Start: 170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial. Issue 7 (July 2021) Authors: Howard, James F; Bril, Vera; Vu, Tuan; Karam, Chafic; Peric, Stojan; Margania, Temur; Murai, Hiroyuki; Bilinska, Malgorzata; Shakarishvili, Roman; Smilowski, Marek; Guglietta, Antonio; Ulrichts, Peter; Vangeneugden, Tony; Utsugisawa, Kimiaki; Verschuuren, Jan; Mantegazza, Renato; De Bleeker, Jan;... Journal: Lancet neurology Issue: Volume 20:Issue 7(2021) Page Start: 526 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗